Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection
Crossref DOI link: https://doi.org/10.1038/s41598-020-64882-9
Published Online: 2020-05-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abutaleb, Nader S.
Seleem, Mohamed N.
Text and Data Mining valid from 2020-05-07
Version of Record valid from 2020-05-07
Article History
Received: 10 January 2020
Accepted: 23 April 2020
First Online: 7 May 2020
Competing interests
: The authors declare no competing interests.